RE:RE:NEWS - Theralase increases revenues 2% in Q1 2015I'm actually surprised the expenditures were that low! added to the TLT team were world renown doctors and researchers. The cost of research is not cheap folks! The marketing ramp up for the TLC-2000 and TLC-3000 is predictable and necessary. You can't expect to sit on the sidelines and hope someone notices. I expect the expenditures to grow in the coming quarters.
Hopefully, the TLC-2000 sales will to help offset some of the expenses. At the same time, we need to be wary of their cash position. I expect a pp announcement in the Fall as excitement builds with the upcoming trials.